Echosens

A new #HDV study performed in 230 patients confirms #FibroScan's high diagnostic value for detecting advanced fibrosis and cirrhosis in patients with chronic hepatitis delta. ✴️ FibroScan® demonstrated strong diagnostic performance with AUROC of 0.88 and 0.86 for advanced fibrosis and cirrhosis respectively, outperforming APRI and FIB-4. Based on the data, a cut-off value of >12kPa was identified for detecting #cirrhosis with excellent specificity and sensitivity, while values below 6kPa could be used to totally exclude significant #fibrosis. ➡️ These findings support the use of FibroScan® as a Non-Invasive Test for stratifying HDV patients and limiting the use of liver biopsy. Read the article here: https://lnkd.in/eENeNmju #LiverHealthMatters

💡 New AASLD practice guidance highlights the key role of FibroScan® in aiding in both the identification of patients who may be eligible for resmetirom and assessing response to therapy. Liver stiffness measurement (LSM) by VCTE™ is recommended:  • For patient selection, to help identify MASH patients with F2-F3, with suggested LSM range between 8 and 15 to 20 kPa.  • To exclude patients with evidence of compensated/decompensated cirrhosis who should not be considered for treatment, including those when LSM ≥20 kPa. • To utilize changes in LSM in combination with other clinical factors to assess treatment response at 12 months. ⭐ FibroScan® is a recommended option for patient selection and therapeutic monitoring to support clinical decision-making. By advancing non-invasive liver health management, we’re helping to deliver better patient outcomes with resmetirom therapy and beyond. #LiverHealth #LiverHealthMatters #FibroScan Link to AASLD guidance: https://lnkd.in/euxRkSUE 

📢 “Liver health is no longer just a specialist’s domain. It’s a growing public health issue that primary care providers are uniquely positioned to address. Non-invasive liver tests should be as common as screenings for diabetes, hypertension, and cholesterol, especially for patients struggling with obesity. Together, we can help people love their livers.”   👏 In a recent Physician's Weekly article, our Chief Medical Officer, Dr. Victor de Lédinghen, discusses the unique role PCPs play in the fight against liver disease with access to non-invasive tests like FibroScan® that are safe, cost-effective, and easy to use.   Read the full article here: https://lnkd.in/eqNHiczD   #PrimaryCare #PrimaryCareProviders #LiverHealth #LiverHealthMatters #FibroScan

🎉 Echosens is wishing you a very happy and prosperous Diwali 🎇 As we celebrate the Festival of Lights, may your life be illuminated with new opportunities and abundant blessings.

📣 ACG 2024 begins tomorrow in Philadelphia, USA: come and meet the Echosens team at the booth N°873! We are excited to share the latest product innovations and introducing you to Next Generation #FibroScan at the booth! More information here ➡️ https://lnkd.in/epQi8ANQ #Liverhealthmatters

With 20 years of hands-on clinical experience using FibroScan®, our Chief Medical Officer, Dr. Victor de Lédinghen, MD, PhD, is now driving its future. His expertise is key in advancing the development of FibroScan®, ensuring it continues to lead in liver health diagnostics.

⏰5 Days Left! The Liver Health Super Shaper Award honors healthcare professionals transforming liver care. 🌟Winners will direct a $10,000 donation to a health charity of their choice. Nominate a deserving hero now and make a difference ➡️ https://lnkd.in/gYF2MyjA #LiverHealthMatters #FibroScan

📺 Non perdete il nostro prossimo #webinar il 22 ottobre alle 19:00 : Overview sull’utilizzo della #SpleenStiffness negli algoritmi diagnostici dell’ipertensione portale pesentato da esperti nella salute del fegato : Prof. Antonio Colecchia, Prof. Filippo Schepis e Prof. Angelo Armandi. Spiegheranno attraverso una rassegna storica come la misurazione della rigidità della #Milza, sia passata dall’utilizzo di un’onda di taglio a 50Hz nei primi studi ai 100Hz attuali, con l’algoritmo dedicato del #FibroScan® Expert 630 e, come i dati clinici ottenuti siano un marcatore correlato dell'ipertensione portale. 📍 Unisciti a noi: https://lnkd.in/e-Rz6QbT #LiverHealthMatters

Echosens is proud to honor those making monumental strides in liver disease management. Nominate exceptional healthcare heroes and help shine a spotlight on their groundbreaking work. 💡 Two deserving winners will each receive $10,000 for a health charity of their choice. Submit a nomination now ➡️ https://lnkd.in/gYF2MyjA #LiverHealthMatters #FibroScan

UEG Week 2024, organized by UEG - United European Gastroenterology, starts tomorrow in Vienna, Austria! We look forward to sharing the latest product innovations and showing you all FibroScan products at booth N°47! #UEGWeek #FibroScan #Liverhealthmatters